Interferon-Alpha in the Treatment of Multiple Myeloma
Journal:
Current Drug Targets
Volume:
12
Page:
437-446
Author(s):
Teh Liane Khoo, Annette Juul Vangsted, Douglas Joshua and John Gibson
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
239-253
Author(s):
D. Chen, M. Frezza, S. Schmitt, J. Kanwar and Q. P. Dou
Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
254-284
Author(s):
G. K. Lloyd, M. A. Palladino, A. Younes, E. Valashi, M. A. Spear, C. M. Sloss, A. M. Roccaro, P. G. Richardson, F. Pajonk, H. Ovaa, Y. Oki, S. T.C. Neuteboom, C. P. Miller, D. J. McConkey, W. McBride, B. C. Potts, K. S. Lam, P. R. Jensen, M. Groll, I. M. Ghobrial, W. Fenical, J. C. Cusack, D. Chauhan, J. Chandra, B. Bonavida, C. Berkers, S. Baritaki, K. C. Anderson and M. X. Albitar
Second Generation Proteasome Inhibitors: Carfilzomib and Immunoproteasome-Specific Inhibitors (IPSIs)
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
285-295
Author(s):
D. J. Kuhn, R. Z. Orlowski and C. C. Bjorklund
Targeting Proteasomes with Naturally Occurring Compounds in Cancer Treatment
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
307-324
Author(s):
V. Cecarini, M. Cuccioloni, M. Mozzicafreddo, L. Bonfili, M. Angeletti and A. M. Eleuteri
Autophagy: Molecular Mechanisms and their Implications for Anticancer Therapies
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
357-379
Author(s):
S. Meschini, M. Condello, P. Lista and G. Arancia
The Many Faces of Glutathione Transferase Pi
Journal:
Current Molecular Medicine
Volume:
11
Page:
129-139
Author(s):
O. Vasieva
Pathobiology and Prevention of Cancer Chemotherapy-Induced Bone Growth Arrest, Bone Loss, and Osteonecrosis
Journal:
Current Molecular Medicine
Volume:
11
Page:
140-151
Author(s):
C. Fan, B. K. Foster, W. H. Wallace and C. J. Xian
Progress in the Development of Bestatin Analogues as Aminopeptidases Inhibitors
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
964-976
Author(s):
L. Chen, Y. Teng and W. Xu
Non-Genotoxic p53-Activators and their Significance as Antitumor Therapy of Future
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
1038-1049
Author(s):
S. K. Nayak, P. S. Panesar and H. Kumar